Published on: 20/01/2022 – 14:27
The UN-backed agency announced Thursday that it has signed agreements with more than a dozen integrated drug manufacturers to manufacture Merck’s COVID-19 tablets to supply 105 developing countries.
The Medicines Patent Pool said the agreements allow pharmaceutical companies to make all of the molnupiravir products and only those that are completed.
Molnupiravir, developed by Merck and Ridgeback Therapeutics, is said to have reduced clinical risk among patients with early symptoms of COVID-19. Britain, the European Union and the US have approved its use in recent months.
“It plays an important role in ensuring that the global demand for COVID-19 is needed,” said Charles Gore, chief of Medicines Patent Pool.
The group says 27 generic manufacturers in 11 countries, including Bangladesh, China, Egypt, Vietnam, Kenya and South Africa, have recently started making Merck tablets.
Antiretroviral drugs that people can take home to reduce their symptoms and speed up recovery can be difficult, reduce the number of hospitals and help combat epidemics in poor countries with poor medical systems.
It can also help in two ways of the epidemic: treatment and prevention and prevention, especially through vaccination.
Merck announced in October that it would allow other drugs to form molnupiravir. Even Merck, Ridgeback Biotherapeutics or Emory University, which developed the drug, will not receive any compensation while COVID-19 is still a global emergency from the commercialization of molnupiravir manufactured by generic companies.
To date, no coronavirus vaccine manufacturer has approved the same agreement.
Original Article reposted fromSource link
Disclaimer: The website autopost contents from credible news sources and we are not the original creators. If we Have added some content that belongs to you or your organization by mistake, We are sorry for that. We apologize for that and assure you that this won’t be repeated in future. If you are the rightful owner of the content used in our Website, please mail us with your Name, Organization Name, Contact Details, Copyright infringing URL and Copyright Proof (URL or Legal Document) aT spacksdigital @ gmail.com
I assure you that, I will remove the infringing content Within 48 Hours.